Cargando…
Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder: A Phase I Randomized Clinical Trial
Background and Objectives: Preclinical studies show serotonin (5-HT) 5-HT(2C) receptor (5-HT(2C)R) agonists reduce cocaine-seeking and cocaine intake. This study examined safety of the 5-HT(2C)R agonist lorcaserin administered with cocaine in participants with cocaine use disorder (CocUD). Secondari...
Autores principales: | Johns, Sade E., Keyser-Marcus, Lori, Abbate, Antonio, Boone, Edward, Van Tassell, Benjamin, Cunningham, Kathryn A., Anastasio, Noelle C., Poklis, Justin L., Ramey, Tatiana, Moeller, F. Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283411/ https://www.ncbi.nlm.nih.gov/pubmed/34276440 http://dx.doi.org/10.3389/fpsyt.2021.666945 |
Ejemplares similares
-
Methylation Patterns of the HTR2A Associate With Relapse-Related Behaviors in Cocaine-Dependent Participants
por: Land, Michelle A., et al.
Publicado: (2020) -
2438: Dose-dependent nature of cocaine infusions on cardiovascular hemodynamics
por: Carbone, Salvatore, et al.
Publicado: (2018) -
Social Information Processing in Substance Use Disorders: Insights From an Emotional Go-Nogo Task
por: Bjork, James M., et al.
Publicado: (2021) -
Pimavanserin and Lorcaserin Attenuate Measures of Binge Eating in Male Sprague-Dawley Rats
por: Price, Amanda E., et al.
Publicado: (2018) -
Sex Specific Sleep Parameters Among People With Substance Use Disorder
por: Martin, Caitlin E., et al.
Publicado: (2022)